<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Dankr.ca</provider_name><provider_url>https://dankr.ca</provider_url><author_name>Dankr NewsBot</author_name><author_url>https://dankr.ca/author/dankr-newsbot</author_url><title>Spike in medical cannabis demand catches Tilray off guard CHRISTINA PELLEGRINI CANNABIS INDUSTRY REPORTER Tilray chief executive Brendan Kennedy at company's head office in Nanaimo, B.C., on Nov. 29, 2017. CHAD HIPOLITO/THE Tilray products such as capsules, oils, and dried marijuana at the company's head office in Nanaimo, B.C., on Nov. 29, 2017. CHAD  Mike Gorenstein, CEO at Cronos, in New York, on Sept. 4, 2018. BRENDAN MCDERMID/REUTERS | Dankr.ca - Your Toronto Connection</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content"&gt;&lt;a href="https://dankr.ca/news/spike-in-medical-cannabis-demand-catches-tilray-off-guard/attachment/news-4860"&gt;Spike in medical cannabis demand catches Tilray off guard CHRISTINA PELLEGRINI CANNABIS INDUSTRY REPORTER  Tilray chief executive Brendan Kennedy at company&#x2019;s head office in Nanaimo, B.C., on Nov. 29, 2017. CHAD HIPOLITO/THE  Tilray products such as capsules, oils, and dried marijuana at the company&#x2019;s head office in Nanaimo, B.C., on Nov. 29, 2017. CHAD   Mike Gorenstein, CEO at Cronos, in New York, on Sept. 4, 2018. BRENDAN MCDERMID/REUTERS&lt;/a&gt;&lt;/blockquote&gt;
&lt;script type='text/javascript'&gt;
&lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
		/*! This file is auto-generated */
		!function(c,d){"use strict";var e=!1,n=!1;if(d.querySelector)if(c.addEventListener)e=!0;if(c.wp=c.wp||{},!c.wp.receiveEmbedMessage)if(c.wp.receiveEmbedMessage=function(e){var t=e.data;if(t)if(t.secret||t.message||t.value)if(!/[^a-zA-Z0-9]/.test(t.secret)){for(var r,a,i,s=d.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),n=d.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),o=0;o&lt;n.length;o++)n[o].style.display="none";for(o=0;o&lt;s.length;o++)if(r=s[o],e.source===r.contentWindow){if(r.removeAttribute("style"),"height"===t.message){if(1e3&lt;(i=parseInt(t.value,10)))i=1e3;else if(~~i&lt;200)i=200;r.height=i}if("link"===t.message)if(a=d.createElement("a"),i=d.createElement("a"),a.href=r.getAttribute("src"),i.href=t.value,i.host===a.host)if(d.activeElement===r)c.top.location.href=t.value}}},e)c.addEventListener("message",c.wp.receiveEmbedMessage,!1),d.addEventListener("DOMContentLoaded",t,!1),c.addEventListener("load",t,!1);function t(){if(!n){n=!0;for(var e,t,r=-1!==navigator.appVersion.indexOf("MSIE 10"),a=!!navigator.userAgent.match(/Trident.*rv:11\./),i=d.querySelectorAll("iframe.wp-embedded-content"),s=0;s&lt;i.length;s++){if(!(e=i[s]).getAttribute("data-secret"))t=Math.random().toString(36).substr(2,10),e.src+="#?secret="+t,e.setAttribute("data-secret",t);if(r||a)(t=e.cloneNode(!0)).removeAttribute("security"),e.parentNode.replaceChild(t,e)}}}}(window,document);
//--&gt;&lt;!]]&gt;
&lt;/script&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://dankr.ca/news/spike-in-medical-cannabis-demand-catches-tilray-off-guard/attachment/news-4860/embed" width="600" height="338" title="&#x201C;Spike in medical cannabis demand catches Tilray off guard CHRISTINA PELLEGRINI CANNABIS INDUSTRY REPORTER  Tilray chief executive Brendan Kennedy at company&#x2019;s head office in Nanaimo, B.C., on Nov. 29, 2017. CHAD HIPOLITO/THE  Tilray products such as capsules, oils, and dried marijuana at the company&#x2019;s head office in Nanaimo, B.C., on Nov. 29, 2017. CHAD   Mike Gorenstein, CEO at Cronos, in New York, on Sept. 4, 2018. BRENDAN MCDERMID/REUTERS&#x201D; &#x2014; Dankr.ca" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;</html><thumbnail_url>https://i0.wp.com/dankr.ca/wp-content/uploads/2018/11/news-50.jpg?fit=620%2C413&amp;ssl=1</thumbnail_url><thumbnail_width>620</thumbnail_width><thumbnail_height>413</thumbnail_height></oembed>
